作者: Sangeeta D. Sule , Jeffrey J. Fadrowski , Barbara A. Fivush , Gregory Gorman , Susan L. Furth
DOI: 10.1007/S00467-007-0591-2
关键词: Nephrology 、 Medicine 、 Kidney 、 Internal medicine 、 Intensive care medicine 、 Autoimmune disease 、 Kidney disease 、 Dialysis 、 Disease 、 Hemodialysis 、 End stage renal disease
摘要: Systemic lupus erythematosus (SLE) is an autoimmune disease that affects between five and ten thousand children in the USA. Kidney may progress to end-stage renal (ESRD) subsequent need for dialysis therapy a significant number of with SLE. We performed cross-sectional analysis comparing achievement National Foundation/Kidney Disease Outcomes Quality Initiative clinical targets pediatric patients SLE maintained on hemodialysis (HD) other causes ESRD. Ninety-seven unique two control groups—1,823 ESRD 694 glomerulonephritis—were identified End Stage Renal Clinical Performance Measures 2000–2004 Project Years. were older, female black race predominance compared both groups. Pediatric HD secondary less likely meet albumin more have vascular catheters than causes. These findings be associated increased morbidity mortality deserve further study.